IPHA Form 6-K: Report of foreign private issuer, 2024

Innate Pharma SA Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

2024-12-20: Form 6-K; Period of report 2024-12-20; Description 6-K; Document a6k-iphx241220.htm.
2024-12-09: Form 6-K; Period of report 2024-12-09; Description 6-K; Document a6k-iphx241209.htm.
2024-12-06: Form 6-K; Period of report 2024-12-06; Description 6-K; Document a241206-6kiph.htm.
2024-12-03: Form 6-K; Period of report 2024-12-03; Description 6-K; Document a6k-iphx241203.htm.

Filed	Form	Period of report	Description	Document
2024-12-20	6-K	2024-12-20	6-K	a6k-iphx241220.htm
2024-12-09	6-K	2024-12-09	6-K	a6k-iphx241209.htm
2024-12-06	6-K	2024-12-06	6-K	a241206-6kiph.htm
2024-12-03	6-K	2024-12-03	6-K	a6k-iphx241203.htm
2024-11-20	6-K	2024-11-20	6-K	a6k-iphx241120.htm
2024-11-19	6-K	2024-11-19	6-K	a6k-iphx241119.htm
2024-11-13	6-K	2024-11-13	6-K	a241113-6kiph.htm
2024-11-08	6-K	2024-11-08	6-K	a6k-iphx241108.htm
2024-11-07	6-K	2024-11-07	6-K	a6ktemplate-iphnovember7.htm
2024-10-29	6-K	2024-10-29	6-K	a6k-iphx241029.htm
2024-10-15	6-K	2024-10-14	6-K	a6k-iphx241014.htm
2024-09-30	6-K	2024-09-30	6-K	a6k-iphx240930.htm
2024-09-23	6-K	2024-09-23	6-K	a6k-iphx240923.htm
2024-09-12	6-K	2024-06-30	6-K	inpha-20240630.htm
2024-09-12	6-K	2024-09-12	6-K	a6k-iphx240912.htm
2024-09-09	6-K	2024-09-09	6-K	a6k-iphx240909.htm
2024-09-05	6-K	2024-09-05	6-K	a6k-iphx240905.htm
2024-09-04	6-K	2024-09-04	6-K	a6k-iphx240904.htm
2024-07-25	6-K	2024-07-25	6-K	a6k-iphx240710.htm
2024-06-18	6-K	2024-06-18	6-K	a6k-iphx240618.htm
2024-06-17	6-K	2024-06-17	6-K	a6k-iphx240617.htm
2024-06-04	6-K	2024-06-04	6-K	a6k-iphx240604.htm
2024-05-28	6-K	2024-05-28	6-K	a6k-iphx240528.htm
2024-05-24	6-K	2024-05-24	6-K	a6k-iphx240524.htm
2024-05-23	6-K	2024-05-23	6-K	a6kiphmay2320241.htm
2024-05-15	6-K	2024-05-15	6-K	a6k-iphx240515.htm
2024-05-14	6-K	2024-05-14	6-K	a6k-iphx240514.htm
2024-05-07	6-K	2024-05-07	6-K	a6k-iphx240507.htm
2024-04-15	6-K	2024-04-15	6-K	a240415-6kiph.htm
2024-04-15	6-K	2024-04-15	6-K	a2404126kiph.htm
2024-04-10	6-K	2024-04-10	6-K	a240410-6k.htm
2024-03-21	6-K	2024-03-21	6-K	a6k-iphx240321summary.htm
2024-03-21	6-K	2024-03-21	6-K	a6k-iphx240321.htm
2024-03-19	6-K	2024-03-19	6-K	a6k-iphx2402211.htm
2024-03-14	6-K	2024-03-14	6-K	a6k-iphx240312.htm
2024-03-06	6-K	2024-03-06	6-K	a6kincorporated-iphx240603.htm
2024-03-06	6-K	2024-03-06	6-K	a6k-iphx240306.htm
2024-02-21	6-K	2024-02-21	6-K	a6k-iphx240221.htm
2024-02-06	6-K	2024-02-06	6-K	innatepharma6-k262024.htm
2024-01-12	6-K	2024-01-12	INNATE PHARMA S.A. 6-K	a53881086.htm
2024-01-05	6-K	2024-01-04	INNATE PHARMA S.A. 6-K	a53877934.htm
2024-01-04	6-K	2024-01-04	INNATE PHARMA S.A. 6-K	a53876727.htm
2024-01-04	6-K	2024-01-04	INNATE PHARMA 6-K	a53876911.htm